EDITORIALS
Stage I NSCLC: elucidating the prognostic factors
Division of Thoracic Surgery, Duke University Health System, Durham, North Carolina, USA
Correspondence to:
Dr David H Harpole, jr, Duke University Medical Center, Box 3627, Durham, NC 27710, USA; harpo002@mc.duke.edu
| The first 150 words of the full text of this article appear below. |
Non-small cell lung cancer (NSCLC) remains the number one cause of cancer related deaths.1 While early stage NSCLC portends the best survival following complete surgical resection, as many as 37% of patients with stage I disease have recurrence within 5 years of diagnosis.2 Several studies have investigated the role of adjuvant chemotherapy for early stage disease.3–6 However, the benefit of adjuvant therapy was mainly in patients with stage II and IIIA disease. Significant progress in improving the survival of patients with stage I NSCLC is lacking.
In this issue, Hung and colleagues7 address two very important issues with regard to the management of early stage NSCLC (see page 192): (1) the prognostic predictors of survival in patients with recurrence and (2) the optimal treatment for recurrent disease. In this retrospective study of 970 patients with resected stage I NSCLC, the clinicopathological characteristics of 123 patients with recurrence were
Relevant Articles
- Post-recurrence survival in completely resected stage I non-small cell lung cancer with local recurrence
- J-J Hung, W-H Hsu, C-C Hsieh, B-S Huang, M-H Huang, J-S Liu, and Y-C Wu
Thorax 2009 64: 192-196.[Abstract] [Full Text] [PDF]
- Airwaves
- Wisia Wedzicha
Thorax 2009 64: i.[Extract] [Full Text] [PDF]
Register for free content
The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.
Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.
